相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke
Ann Marie Navar-Boggan et al.
AMERICAN HEART JOURNAL (2015)
Allopurinol and Progression of CKD and Cardiovascular Events: Long-term Follow-up of a Randomized Clinical Trial
Marian Goicoechea et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Allopurinol use and risk of non-fatal acute myocardial infarction
Francisco J. de Abajo et al.
HEART (2015)
Patient Characteristics and Risk of Bleeding With Dabigatran in Atrial Fibrillation Reply
Inmaculada Hernandez et al.
JAMA INTERNAL MEDICINE (2015)
Allopurinol initiation and all-cause mortality in the general population
Maureen Dubreuil et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients
Dilara Bayram et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2015)
Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study
Sumeet S. Chugh et al.
CIRCULATION (2014)
Contemporary Trends of Hospitalization for Atrial Fibrillation in the United States, 2000 Through 2010 Implications for Healthcare Planning
Nileshkumar J. Patel et al.
CIRCULATION (2014)
β-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction Post Hoc Analysis From the CHARISMA Trial
Sripal Bangalore et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2014)
Allopurinol Initiation and Change in Blood Pressure in Older Adults With Hypertension
Catherine J. Beattie et al.
HYPERTENSION (2014)
Allopurinol Therapy in Gout Patients Does Not Associate with Beneficial Cardiovascular Outcomes: A Population-Based Matched-Cohort Study
Victor C. Kok et al.
PLOS ONE (2014)
Allopurinol Reduces Left Ventricular Mass in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy
Benjamin R. Szwejkowski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
High-Dose Allopurinol Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease
Sushma Rekhraj et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease
Sripal Bangalore et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries
Victoria L. Tseng et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Xanthine Oxidase Inhibition Prevents Atrial Fibrillation in a Canine Model of Atrial Pacing-Induced left Ventricular Dysfunction
Masao Sakabe et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2012)
A systematic review of validated methods for identifying atrial fibrillation using administrative data
Paul N. Jensen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients
Ali Dogan et al.
BLOOD PRESSURE (2011)
Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States
Michael H. Kim et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
Pathophysiological Mechanisms of Atrial Fibrillation: A Translational Appraisal
Ulrich Schotten et al.
PHYSIOLOGICAL REVIEWS (2011)
Gout, Allopurinol Use, and Heart Failure Outcomes
George Thanassoulis et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Marian Goicoechea et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Three-Year Outcomes for Medicare Beneficiaries Who Survive Intensive Care
Hannah Wunsch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial
Awsan Noman et al.
LANCET (2010)
Opportunities for improving medication use and monitoring in gout
J. A. Singh et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Association between allopurinol and mortality in heart failure patients: a long-term follow-up study
L. Wei et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Allopurinol and mortality in hyperuricaemic patients
Andrew J. Luk et al.
RHEUMATOLOGY (2009)
Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension - A randomized trial
Daniel I. Feig et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Effects of extended-release metoprolol succinate inpatients undergoing non-cardiac surgery (POISE trial):: a randomised controlled trial
P. J. Devereaux et al.
LANCET (2008)
Meta-analysis of 94,492 patients with hypertension treated with beta Blockers to determine the risk of new-onset diabetes Mellitus
Sripal Bangalore et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Gout medication treatment patterns and adherence to standards of care from a managed care perspective
CA Sarawate et al.
MAYO CLINIC PROCEEDINGS (2006)
Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol
P Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure
N Hanna et al.
CARDIOVASCULAR RESEARCH (2004)
Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy
LB Stull et al.
CIRCULATION RESEARCH (2004)
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality - The Framingham Heart Study
TJ Wang et al.
CIRCULATION (2003)
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure - Results from 2 placebo-controlled studies
W Doehner et al.
CIRCULATION (2002)
Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
AS Go et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Epidemiology and natural history of atrial fibrillation: Clinical implications
SS Chugh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension
R Butler et al.
HYPERTENSION (2000)
分享论文
